HARP — Harpoon Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Harpoon Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	89.5	148	126	135	53.1
Prepaid Expenses
Total Current Assets	90.2	151	130	138	54.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.78	18.4	16.8	15.4	18.1
Long Term Investments
Other Long Term Assets
Total Assets	103	177	172	155	73.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	11.9	22.5	47.9	59.1	52.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	26.5	82.4	118	97.4	68.3
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	76.1	94.2	53.8	58.1	5.4
Total Liabilities & Shareholders' Equity	103	177	172	155	73.7
Total Common Shares Outstanding